SiftMed has raised new funding led by Staircase Ventures to expand its AI platform for medical claims review. The company said the round brings its total capital raised to over $10 million, with continued support from Pelorus VC and a group of Verafin founders.
SiftMed did not disclose the size of the latest round, its round classification, or valuation in the announcement.
SiftMed organizes, reviews, and extracts insight from medical claim files for insurance carriers, independent medical examiners, legal teams, and life care planners. Its core promise is simple: reduce the time experts spend searching through medical records and help them focus on judgment.
The signal is not just automation. In medical claims, AI must be traceable enough to hold up when challenged by a regulator, claimant, or court
What SiftMed is solving
Medical claims often depend on facts buried inside hundreds or thousands of pages. Those facts can include pre-existing conditions, treatment gaps, causation evidence, and details that influence reserves or settlement decisions.
SiftMed says the current review process is slow, manual, and inconsistent because skilled experts spend too much time on document triage. Its platform uses AI to organize, analyze, extract, and generate insights from claim files, cutting turnaround time by 50–70%.
The company is now pushing deeper into insurance workflows, especially for carriers handling accident benefits, bodily injury, and disability claims.
Why this funding matters
Insurance carriers have been looking at AI for claims review for years, but general-purpose tools have struggled in a space where every output needs to be defensible.
That is where SiftMed is positioning itself. The company says its platform runs claims investigation from intake and organization through AI-driven analysis, with results populated into a final report and traced back to source material.
This source-linked approach matters because claims teams cannot rely on black-box summaries alone. They need to understand where each insight came from, whether it is accurate, and whether it can support a decision under scrutiny.
What comes next
SiftMed says the new capital will support three priorities: deeper auditability and reporting features, growth of its insurance-focused product and engineering teams, and expansion with carriers, IMEs, and legal teams already using the platform.
The company is a roughly 30-person team based in St. John’s, Newfoundland, and is hiring across product, engineering, and marketing.
For the market, SiftMed’s funding points to a practical reality for healthcare and insurance AI: speed is useful, but trust is the adoption layer. The next wave of claims AI will need citations, audit trails, workflow fit, and human accountability built into the product from the start.
Source: SiftMed Official
